MétaCan
Menu
Retour à la cohorte
Enregistrement W1836956342 · doi:10.1093/pch/8.8.511

Use of propofol sedation in the paediatric emergency department

2003· article· en· W1836956342 sur OpenAlexaffabout
Peggy Chang, David Warren, Gary Joubert, Michael Rieder

Notice bibliographique

RevuePaediatrics & Child Health · 2003
Typearticle
Langueen
DomaineMedicine
ThématiqueAnesthesia and Sedative Agents
Établissements canadiensChildren's Hospital of Western Ontario
Organismes subventionnairesnon disponible
Mots-clésPropofolMedicineSedationEmergency departmentHypoxemiaAnesthesiaAnxietyIntensive care medicineAmbulatorySurgery

Résumé

récupéré en direct d'OpenAlex

Your colleagues in the emergency department are very keen to start using propofol for conscious sedation of children who require reduction of fractures or other painful procedures in the emergency department. They have had good experience using this drug with adult patients and are comfortable using it. When this is discussed at the pharmacy and therapeutics committee, one of the paediatric intensive care physicians raises the issue of the safety of propofol for children. The chair of the committee would like your input. The management of acute pain and anxiety in children undergoing diagnostic or therapeutic procedures is an on-going challenge, especially in urgent care settings. Analgesia and sedation are increasingly being used to reduce the pain and anxiety associated with urgent and acute care of children (1). This raises new issues for clinicians regarding the selection of the appropriate agent. Propofol (2,6-diisopropylphenol) is a nonopioid, nonbarbiturate, short-acting anesthetic agent that must be administered intravenously (2). Although originally confined to operating rooms and intensive care units, propofol use is becoming more popular in ambulatory care areas to facilitate short procedures, because it has both the advantage of rapid induction and recovery time. In the operating room, propofol has been used extensively for paediatric anesthesia with a good track record in terms of efficacy and safety (3). The common adverse effects associated with propofol therapy include cardiopulmonary depression, upper airway obstruction, hypoventilation and apnea leading to hypoxemia (in up to 10% of patients) (4–6). A recent major issue with respect to the use of propofol has been the use of this drug for sedation of paediatric intensive care patients. This has been reinforced by a warning from Health Canada that propofol use is contraindicated for patients under 18 years of age in intensive care units (7). A potentially fatal complication known as ‘propofol infusion syndrome’ has been described in critically ill children given long term propofol infusion, the syndrome being characterized by the development of severe metabolic acidosis and rhabdomyolysis associated with hepatomegaly, lipemia, myocardial failure and hyperkalemia (7,8). This syndrome appears to occur primarily with long term propofol use in critically ill children who often have serious underlying pathology or are being treated with multiple drugs that may alter propofol metabolism, rather than with the use of propofol for brief procedural sedation. Thus, the issues with which Health Canada is concerned regarding propofol use in paediatric intensive care units are probably not germane to the use of propofol in the emergency department. However, there are other issues with respect to the use of propofol for procedural sedation. As propofol does not have analgesic properties, concurrent opioid therapy using agents such as fentanyl or morphine is common, but this can be associated with an increased risk of respiration depression and hypotension. Propofol can interact in a synergistic manner with opioids as well as decrease elimination and distribution clearance of opioids related to the metabolic alteration of opioid clearance. Hence, plasma concentration of opioids (and opioid effects) can increase in the face of concurrent therapy with propofol. As well, opioids may decrease propofol elimination clearance. It should be remembered by all clinicians using propofol that this agent was developed initially for use in the operating room, and thus, patients undergoing sedation for diagnostic or therapeutic procedures with propofol (or indeed, any conscious sedation) should be carefully monitored (9,10). Before proceeding, informed consent must be obtained and the clinician must ensure that the child has fasted for an appropriate period of time. During the procedural sedation, basic monitoring should include continuous assessment of peripheral blood oxygen saturation, respiratory rate and heart rate monitoring, with regular intermittent blood pressure measurement and assessment of depth of sedation using an appropriate technique or scale. Expert personnel and facilities for securing and maintaining a patent airway and providing oxygen and artificial ventilation for children of the age in question must be immediately available. Personnel who are experts in cardiopulmonary resuscitation in children must always be immediately available. All children receiving propofol must have a secure intravenous access in place. Provisions must be made for monitoring for ongoing titration of the propofol dose by personnel who are experts in such assessments. How will we answer the question raised by our colleagues in the emergency department? Studies to date have demonstrated that propofol has comparable amnestic effects as ketamine and midazolam for procedural sedation (4–6). Advantages of propofol with respect to midazolam are more rapid onset of sedation, shorter recovery time, smoother emergence and antiemetic properties. Also, there is a relative lack of effects on intracranial pressure with propofol compared with ketamine. However, disadvantages of propofol include relatively high incidences of hypotension and apnea compared with ketamine and midazolam. Thus, propofol may be a useful agent in the paediatric emergency department, especially when it is important not to increase intracranial pressure, but the decision to use propofol means that: Facilities for continuous monitoring of heart rate and oxygen saturation must be available; Personnel in attendance must be expert in securing and maintaining an airway in children, including by use of endotracheal intubation; There must be adequate facilities to recover the patient after the procedure, including monitoring as described above; and The drug should be given slowly with close attention to oxygenation, level of consciousness and blood pressure.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,002
score de la tête « metaresearch » (Gemma)0,011
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: aucune
GenreSignal candidat: Empirique · Signal consensuel: aucune
Score de désaccord entre enseignants0,005
Score d'incertitude au seuil0,015

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0020,011
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0010,001
Communication savante0,0010,002
Science ouverte0,0010,001
Intégrité de la recherche0,0010,004
Charge utile insuffisante (le modèle a refusé de juger)0,0050,002

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,040
Tête enseignante GPT0,303
Écart entre enseignants0,263 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations3
Publié2003
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revuePaediatrics & Child HealthMême sujetAnesthesia and Sedative AgentsTravaux en français237 207